The stock has been consolidating for a long time and the quarter was pretty good.

Risk not only was realized in silver, but to varying degrees also gold and gold/silver stocks and the two metals that tend to follow silver, platinum and palladium.

The Dow Jones Industrial Average, Nasdaq Composite, and S&P 500 Index are all comfortably higher at midday, pushing aside a lackluster open.

Large-cap biopharma offers stable growth and dividends, outperforming the S&P 500 in early 2026. With Gilead up 46% and Pfizer yielding 6%, the sector remains a key volatility hedge following successful U.S. manufacturing negotiations.

Oracle shares rose about 3.6% after the company announced plans to raise up to $50 billion to expand cloud capacity.

The Canadian Dollar extends its losses against the US Dollar on Monday, as renewed Greenback strength and falling Oil prices weigh on the commodity-linked Loonie.

The reality is that while stocks have hit new all-time highs, things have been troubling for the banks/ financial firms “behind the scenes” for months now.